<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0835">
 <label>167</label>
 <mixed-citation publication-type="other" id="or0125">The use of tocilizumab in the management of patients who have severe COVID-19 with suspected pulmonary hyperinflammation - full text view - 
  <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov" id="ir0610" xmlns:xlink="http://www.w3.org/1999/xlink">ClinicalTrials.gov</ext-link>, (n.d.). 
  <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT04377750" id="ir0615" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT04377750</ext-link> (accessed May 20, 2020).
 </mixed-citation>
</ref>
